People dying of COVID while life-saving drugs go unused, doctors say

21 May 2022 - Top doctors have warned that vulnerable patients who test positive to COVID-19 are missing out on ...

Read more →

DUSC utilisation analysis public release documents

25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...

Read more →

Are we measuring what matters most on uptake to medicines in England?

16 November 2021 - VPAS is a voluntary agreement between the UK government and the Association of the British Pharmaceutical ...

Read more →

Drug Utilisation Sub-Committee outcome statement

5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...

Read more →

Docs ‘use rubber stamp for drugs’

9 October 2021 - Pharmacists have raised the alarm over the influence of a US pharmaceutical corporation on Australian doctors ...

Read more →

Competition from biosimilars drives price reductions for biologics in the French single payer health system

6 August 2021 - France has a single payer health insurance system that has the authority to impose pharmaceutical price reductions ...

Read more →

Uptake of medicines for type 2 diabetes mellitus

15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...

Read more →

Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars

18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...

Read more →

Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey

19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...

Read more →

One in four COVID vaccine doses distributed in Australia not yet administered, figures show

17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...

Read more →

Alberta, Canada, begins mandating switches from originator to biosimilar Humira

6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...

Read more →

Australia has surpassed 2 million vaccines but lacks data on second doses

28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...

Read more →

Drug Utilisation SubCommittee utilisation analysis public release documents

18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available. ...

Read more →

Pfizer COVID vaccine: states agree to secrecy over unused jabs

10 March 2021 - Australian states and territories have made a secret agreement not to release weekly data to the public ...

Read more →

Biosimilars: is interchangeability the proof of the pudding?

15 February 2021 - While apparently non‐inferior to originator biologics, other factors need to be considered before switching ...

Read more →